Varex Imaging Corporation Share Price
Equities
VREX
US92214X1063
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.71 USD | -0.43% |
|
+1.12% | -19.74% |
| 11-19 | Varex Imaging Corporation, Q4 2025 Earnings Call, Nov 18, 2025 | |
| 11-18 | Varex Imaging Fiscal Q4 Adjusted Earnings, Revenue Rise; Issues Q1 Outlook | MT |
| Capitalization | 488M 416M 388M 366M 673M 44.22B 735M 4.53B 1.76B 20.84B 1.83B 1.79B 76.04B | P/E ratio 2026 * |
-25.3x | P/E ratio 2027 * | -18.7x |
|---|---|---|---|---|---|
| Enterprise value | 488M 416M 388M 366M 673M 44.22B 735M 4.53B 1.76B 20.84B 1.83B 1.79B 76.04B | EV / Sales 2026 * |
0.56x | EV / Sales 2027 * | 0.54x |
| Free-Float |
94.82% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Varex Imaging Corporation
| 1 day | -0.43% | ||
| 1 week | +1.12% | ||
| Current month | +1.21% | ||
| 1 month | -5.18% | ||
| 3 months | +3.63% | ||
| 6 months | +37.28% | ||
| Current year | -19.74% |
| 1 week | 11.44 |  | 12 |
| 1 month | 9.81 | | 12.34 |
| Current year | 6.76 | | 15.46 |
| 1 year | 6.76 | | 15.53 |
| 3 years | 6.76 | | 23.9 |
| 5 years | 6.76 | | 32.65 |
| 10 years | 6.76 | | 43.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sunny Sanyal
CEO | Chief Executive Officer | 61 | 19/01/2017 |
Sam Maheshwari
DFI | Director of Finance/CFO | 54 | 26/07/2020 |
Victor Garcia
CMP | Compliance Officer | - | 30/09/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Sunny Sanyal
BRD | Director/Board Member | 61 | 26/01/2017 |
Jay Kunkel
BRD | Director/Board Member | 66 | 26/01/2017 |
| Director/Board Member | 67 | 26/01/2017 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.3% | 22 M€ | +4.17% | - |
| 0.15% | 29 M€ | +11.02% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.43% | +1.12% | -24.55% | -41.57% | 488M | |
| -1.98% | -4.53% | +4.49% | -32.77% | 17.45B | |
| -3.23% | -4.47% | +73.19% | +238.77% | 2.52B | |
| -2.90% | +3.75% | -30.77% | -70.46% | 1.96B | |
| -1.11% | -2.39% | -1.65% | -10.12% | 1.11B | |
| -1.13% | -1.26% | +0.09% | -26.23% | 899M | |
| +0.65% | -2.89% | -5.91% | -45.23% | 879M | |
| +0.89% | +2.71% | -15.43% | -43.85% | 710M | |
| -2.49% | -11.02% | +277.58% | - | 495M | |
| -0.39% | -1.92% | -31.91% | -38.23% | 393M | |
| Average | -1.21% | -1.54% | +24.51% | -7.74% | 2.69B | |
| Weighted average by Cap. | -1.90% | -3.62% | +11.06% | -9.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 867M 738M 690M 649M 1.19B 78.5B 1.31B 8.05B 3.12B 37B 3.25B 3.18B 135B | 906M 772M 721M 679M 1.25B 82.09B 1.36B 8.42B 3.27B 38.7B 3.4B 3.33B 141B |
| Net income | -10.54M -8.98M -8.39M -7.89M -14.53M -955M -15.87M -97.9M -37.97M -450M -39.55M -38.71M -1.64B | -11.38M -9.69M -9.05M -8.52M -15.68M -1.03B -17.13M -106M -40.98M -486M -42.68M -41.78M -1.77B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/12/25 | 11.71 $ | -0.43% | 300,386 |
| 11/12/25 | 11.76 $ | +0.51% | 318,110 |
| 10/12/25 | 11.70 $ | +1.56% | 370,216 |
| 09/12/25 | 11.52 $ | +0.52% | 201,951 |
| 08/12/25 | 11.46 $ | -1.04% | 201,653 |
Delayed Quote Nasdaq, December 12, 2025 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VREX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition